About The DABOM
The DABOM is a company based in Seoul (South Korea) founded in 2021. It operates as a B2B and SaaS. The DABOM offers products and services including Exocure TM and Exostation TM. The DABOM operates in a competitive market with competitors including Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.
- Headquarter Seoul, South Korea
- SectorsHealthcareTechnology
- Emailβ’β’β’β’β’β’β’β’
- Website thedabom.com
- Legal Name 주식회사 더다봄
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of The DABOM
The DABOM operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of The DABOM
The DABOM offers a comprehensive portfolio of products and services, including Exocure TM and Exostation TM.
Artificial exosomes for therapeutic medical applications.
System for mass-producing artificial exosomes using AI.
Competitors of The DABOM
The DABOM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Sirnaomics, Acorda, Liquidia and Genedit, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicaldynamics.com | 2010 | San Diego, United States | $67.65M | 54 | Proprietary lab-on-chip platform for nanoparticle isolation is offered. | |
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| acorda.com | 1995 | Ardsley, United States | $66.5M | 109 | Engaged in the development and commercialization of therapies that improve neurological function. | |
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| genedit.com | 2016 | Berkeley, United States | $93.5M | 34 | Genetic medicines are delivered using polymer nanoparticle platforms. | |
| nanosyrinx.com | 2018 | Coventry, United Kingdom | $21.63M | 17 | Drug delivery systems to cell interiors are developed via nanosyringes. | |
| miroculus.com | 2014 | San Francisco, United States | $48.42M | – | MicroRNA profiling platform is developed to detect genes in samples. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | – | Drug delivery solutions via single-walled carbon nanotubes are offered. | |
| arcturusrx.com | 2013 | San Diego, United States | $1.3M | 337 | RNAi technologies are developed for treating rare orphan diseases. |
Detailed competitors of The DABOM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of The DABOM
The website of The DABOM (thedabom.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 56.3% vs previous month
Similar companies to The DABOM
10 companies that operate in the same segment as The DABOM (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about The DABOM
The DABOM was founded in 2021.
The DABOM is headquartered in Seoul, South Korea.
The DABOM is a South Korean company that utilizes microfluidics and artificial intelligence to mass-produce artificial exosomes for nanomedicine. They offer platforms like Exocure TM for therapeutics and Exostation TM for production, focusing on RD and partnerships. Based in Seoul, they participate in conferences and collaborate with institutions for exosome-based innovations, advancing healthcare technology.
The DABOM's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
The DABOM offers Exocure TM and Exostation TM.
The DABOM operates through ,.